$EBS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Emergent BioSolutions Inc.. Get notifications about new insider transactions in Emergent BioSolutions Inc. for free.
Page: < prev 1 2 3 4 5 6 7 ... 21 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2019 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,081 | 0 | 31,782 | 26.7 K to 31.8 K (+19.03 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,081 | 0 | 26,701 | 21.6 K to 26.7 K (+23.50 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 61.01 | 534 | 32,579 | 21,620 | 22.2 K to 21.6 K (-2.41 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Option Exercise | A | 61.01 | 13,929 | 849,808 | 13,929 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 58.71 | 540 | 31,703 | 22,425 | 23 K to 22.4 K (-2.35 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 57.98 | 387 | 22,438 | 22,965 | 23.4 K to 23 K (-1.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 3,483 | 0 | 23,352 | 19.9 K to 23.4 K (+17.53 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 3,483 | 0 | 19,869 | 16.4 K to 19.9 K (+21.26 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 61.01 | 448 | 27,332 | 16,386 | 16.8 K to 16.4 K (-2.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,722 | 0 | 40,681 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,794 | 0 | 50,403 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 61.01 | 36,053 | 2,199,594 | 36,053 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 18,029 | 0 | 60,197 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,430 | 0 | 42,168 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 58.71 | 3,826 | 224,624 | 1,479,018 | 1.5 M to 1.5 M (-0.26 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,722 | 0 | 1,482,844 | 1.5 M to 1.5 M (+0.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 58.47 | 6,987 | 408,530 | 1,473,122 | 1.5 M to 1.5 M (-0.47 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 57.98 | 2,486 | 144,138 | 1,480,109 | 1.5 M to 1.5 M (-0.17 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,794 | 0 | 1,482,595 | 1.5 M to 1.5 M (+0.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 58.24 | 10,369 | 603,891 | 1,472,801 | 1.5 M to 1.5 M (-0.70 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 61.01 | 1,566 | 95,542 | 1,483,170 | 1.5 M to 1.5 M (-0.11 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,430 | 0 | 1,484,736 | 1.5 M to 1.5 M (+0.43 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 59.65 | 10,369 | 618,511 | 1,478,306 | 1.5 M to 1.5 M (-0.70 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 61.01 | 20,321 | 1,239,784 | 20,321 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 5,081 | 0 | 21,696 | 16.6 K to 21.7 K (+30.58 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 5,081 | 0 | 16,615 | 11.5 K to 16.6 K (+44.05 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 58.71 | 5,101 | 299,480 | 157,182 | 162.3 K to 157.2 K (-3.14 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 57.98 | 2,570 | 149,009 | 162,283 | 164.9 K to 162.3 K (-1.56 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 61.01 | 1,714 | 104,571 | 164,853 | 166.6 K to 164.9 K (-1.03 %) |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 13.37 | 3,158 | 42,222 | 0 | |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 13.00 | 4,736 | 61,568 | 0 | |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 20.08 | 1,579 | 31,706 | 0 | |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 18.64 | 8,244 | 153,668 | 0 | |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 69.62 | 3,158 | 219,859 | 48,972 | 52.1 K to 49 K (-6.06 %) |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 13.37 | 3,158 | 42,222 | 52,130 | 49 K to 52.1 K (+6.45 %) |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 69.62 | 4,736 | 329,719 | 48,972 | 53.7 K to 49 K (-8.82 %) |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 13.00 | 4,736 | 61,568 | 53,708 | 49 K to 53.7 K (+9.67 %) |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 69.62 | 1,579 | 109,930 | 48,972 | 50.6 K to 49 K (-3.12 %) |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 20.08 | 1,579 | 31,706 | 50,551 | 49 K to 50.6 K (+3.22 %) |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 69.62 | 8,244 | 573,945 | 48,972 | 57.2 K to 49 K (-14.41 %) |
| Nov 29 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 18.64 | 8,244 | 153,668 | 57,216 | 49 K to 57.2 K (+16.83 %) |
| Nov 28 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 69.59 | 20,832 | 1,449,699 | 1,407,670 | 1.4 M to 1.4 M (-1.46 %) |
| Nov 28 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 69.96 | 25,000 | 1,749,000 | 1,428,502 | 1.5 M to 1.4 M (-1.72 %) |
| Nov 21 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 70.03 | 15,173 | 1,062,565 | 1,453,502 | 1.5 M to 1.5 M (-1.03 %) |
| Nov 21 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 69.54 | 20,000 | 1,390,800 | 1,468,675 | 1.5 M to 1.5 M (-1.34 %) |
| Nov 08 2018 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 70.08 | 1,871 | 131,118 | 18,643 | 20.5 K to 18.6 K (-9.12 %) |
| Nov 08 2018 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 69.48 | 2,371 | 164,738 | 20,514 | 22.9 K to 20.5 K (-10.36 %) |
| Nov 08 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 13.00 | 7,893 | 102,609 | 0 | |
| Nov 08 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 70.00 | 7,893 | 552,510 | 20,963 | 28.9 K to 21 K (-27.35 %) |
| Nov 08 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 13.00 | 7,893 | 102,609 | 28,856 | 21 K to 28.9 K (+37.65 %) |
| Nov 08 2018 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Sell | S | 68.45 | 4,058 | 277,784 | 26,214 | 30.3 K to 26.2 K (-13.41 %) |
| Nov 08 2018 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 68.90 | 8,000 | 551,194 | 33,972 | 42 K to 34 K (-19.06 %) |
| Nov 05 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 25.62 | 6,168 | 158,024 | 0 | |
| Nov 05 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 25.62 | 2,011 | 51,522 | 6,168 | |
| Nov 05 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 64.50 | 6,168 | 397,836 | 29,253 | 35.4 K to 29.3 K (-17.41 %) |
| Nov 05 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 25.62 | 6,168 | 158,024 | 35,421 | 29.3 K to 35.4 K (+21.09 %) |
| Nov 05 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 63.50 | 2,011 | 127,699 | 29,253 | 31.3 K to 29.3 K (-6.43 %) |
| Nov 05 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 25.62 | 2,011 | 51,522 | 31,264 | 29.3 K to 31.3 K (+6.87 %) |
| Oct 19 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 25.62 | 314 | 8,045 | 8,179 | |
| Oct 19 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 61.50 | 314 | 19,311 | 29,253 | 29.6 K to 29.3 K (-1.06 %) |
| Oct 19 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 25.62 | 314 | 8,045 | 29,567 | 29.3 K to 29.6 K (+1.07 %) |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 25.62 | 3,840 | 98,381 | 8,493 | |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 25.62 | 6,165 | 157,947 | 12,333 | |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 25.62 | 6,165 | 157,947 | 18,498 | |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 25.62 | 6,165 | 157,947 | 24,663 | |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 63.50 | 3,840 | 243,840 | 29,253 | 33.1 K to 29.3 K (-11.60 %) |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 25.62 | 3,840 | 98,381 | 33,093 | 29.3 K to 33.1 K (+13.13 %) |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 61.50 | 6,165 | 379,148 | 29,253 | 35.4 K to 29.3 K (-17.41 %) |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 25.62 | 6,165 | 157,947 | 35,418 | 29.3 K to 35.4 K (+21.07 %) |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 60.67 | 661 | 40,103 | 29,253 | 29.9 K to 29.3 K (-2.21 %) |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 60.03 | 6,165 | 370,081 | 29,914 | 36.1 K to 29.9 K (-17.09 %) |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 25.62 | 6,165 | 157,947 | 36,079 | 29.9 K to 36.1 K (+20.61 %) |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 60.15 | 6,165 | 370,855 | 29,914 | 36.1 K to 29.9 K (-17.09 %) |
| Oct 17 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 25.62 | 6,165 | 157,947 | 36,079 | 29.9 K to 36.1 K (+20.61 %) |
| Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Option Exercise | M | 13.38 | 1,319 | 17,648 | 0 | |
| Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Option Exercise | M | 13.38 | 28,220 | 377,584 | 1,319 | |
| Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 65.00 | 1,319 | 85,735 | 166,567 | 167.9 K to 166.6 K (-0.79 %) |
| Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Buy | M | 13.38 | 1,319 | 17,648 | 167,886 | 166.6 K to 167.9 K (+0.79 %) |
| Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 65.00 | 28,220 | 1,834,300 | 166,567 | 194.8 K to 166.6 K (-14.49 %) |
| Sep 18 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Buy | M | 13.38 | 28,220 | 377,584 | 194,787 | 166.6 K to 194.8 K (+16.94 %) |
| Sep 06 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Option Exercise | M | 13.38 | 60,000 | 802,800 | 29,539 | |
| Sep 06 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 59.49 | 30,776 | 1,830,944 | 166,567 | 197.3 K to 166.6 K (-15.60 %) |
| Sep 06 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Sell | S | 60.54 | 60,000 | 3,632,286 | 197,343 | 257.3 K to 197.3 K (-23.32 %) |
| Sep 06 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Buy | M | 13.38 | 60,000 | 802,800 | 257,343 | 197.3 K to 257.3 K (+30.40 %) |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 14.71 | 7,793 | 114,635 | 0 | |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 14.71 | 7,793 | 114,635 | 0 | |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 14.71 | 100 | 1,471 | 7,793 | |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 14.71 | 100 | 1,471 | 7,793 | |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 60.02 | 7,793 | 467,709 | 20,963 | 28.8 K to 21 K (-27.10 %) |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 60.02 | 7,793 | 467,709 | 20,963 | 28.8 K to 21 K (-27.10 %) |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 14.71 | 7,793 | 114,635 | 28,756 | 21 K to 28.8 K (+37.18 %) |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 14.71 | 7,793 | 114,635 | 28,756 | 21 K to 28.8 K (+37.18 %) |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 60.00 | 100 | 6,000 | 20,963 | 21.1 K to 21 K (-0.47 %) |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 60.00 | 100 | 6,000 | 20,963 | 21.1 K to 21 K (-0.47 %) |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 14.71 | 100 | 1,471 | 21,063 | 21 K to 21.1 K (+0.48 %) |
| Aug 23 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 14.71 | 100 | 1,471 | 21,063 | 21 K to 21.1 K (+0.48 %) |
| Aug 15 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 56.57 | 16,318 | 923,109 | 1,488,675 | 1.5 M to 1.5 M (-1.08 %) |
| Aug 15 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 55.50 | 20,000 | 1,110,000 | 1,504,993 | 1.5 M to 1.5 M (-1.31 %) |
| Jul 16 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 54.52 | 2,600 | 141,752 | 1,524,993 | 1.5 M to 1.5 M (-0.17 %) |
| Jul 16 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 54.50 | 12,400 | 675,800 | 1,527,593 | 1.5 M to 1.5 M (-0.81 %) |
| Jul 11 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 53.61 | 15,000 | 804,150 | 1,539,993 | 1.6 M to 1.5 M (-0.96 %) |
| Jun 07 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | Chief Executive Off ... | Sell | S | 52.11 | 15,785 | 822,615 | 197,343 | 213.1 K to 197.3 K (-7.41 %) |
| Jun 07 2018 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 52.16 | 8,375 | 436,876 | 12,588 | 21 K to 12.6 K (-39.95 %) |
| Jun 07 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 53.00 | 7,342 | 389,126 | 20,963 | 28.3 K to 21 K (-25.94 %) |
| Jun 07 2018 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 52.81 | 376 | 19,857 | 22,885 | 23.3 K to 22.9 K (-1.62 %) |
| May 29 2018 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Sell | S | 51.15 | 1,377 | 70,434 | 23,261 | 24.6 K to 23.3 K (-5.59 %) |
| May 24 2018 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Grant | A | 0.00 | 4,895 | 0 | 35,272 | 30.4 K to 35.3 K (+16.11 %) |
| May 24 2018 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Grant | A | 0.00 | 4,895 | 0 | 41,972 | 37.1 K to 42 K (+13.20 %) |
| May 24 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Grant | A | 0.00 | 4,895 | 0 | 28,305 | 23.4 K to 28.3 K (+20.91 %) |
| May 24 2018 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Grant | A | 0.00 | 4,895 | 0 | 48,972 | 44.1 K to 49 K (+11.11 %) |
| May 24 2018 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Grant | A | 0.00 | 4,895 | 0 | 20,963 | 16.1 K to 21 K (+30.46 %) |
| May 24 2018 | EBS | Emergent BioSoluti ... | Zoon Kathryn C | Director | Grant | A | 0.00 | 4,895 | 0 | 24,638 | 19.7 K to 24.6 K (+24.79 %) |
| May 24 2018 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 4,895 | 0 | 48,972 | 44.1 K to 49 K (+11.11 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 48.33 | 19,963 | 964,812 | 19,963 | |
| May 10 2018 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 4,991 | 0 | 11,534 | 6.5 K to 11.5 K (+76.28 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 1,551 | 0 | 6,543 | 5 K to 6.5 K (+31.07 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 4,992 | 0 | 4,992 | 0 to 5 K |
| May 10 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 48.33 | 237 | 11,454 | 16,834 | 17.1 K to 16.8 K (-1.39 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 48.33 | 237 | 11,454 | 16,834 | 17.1 K to 16.8 K (-1.39 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Option Exercise | A | 48.33 | 2,586 | 124,981 | 2,586 | |
| May 10 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Option Exercise | A | 48.33 | 2,586 | 124,981 | 2,586 | |
| May 10 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Grant | A | 0.00 | 646 | 0 | 91,172 | 90.5 K to 91.2 K (+0.71 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Grant | A | 0.00 | 646 | 0 | 91,172 | 90.5 K to 91.2 K (+0.71 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Grant | A | 0.00 | 647 | 0 | 90,526 | 89.9 K to 90.5 K (+0.72 %) |
| May 10 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Grant | A | 0.00 | 647 | 0 | 90,526 | 89.9 K to 90.5 K (+0.72 %) |
| Apr 19 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 13.37 | 7,893 | 105,529 | 0 | |
| Apr 19 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 55.00 | 7,893 | 434,115 | 23,410 | 31.3 K to 23.4 K (-25.21 %) |
| Apr 19 2018 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 13.37 | 7,893 | 105,529 | 31,303 | 23.4 K to 31.3 K (+33.72 %) |
| Mar 13 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 13,237 | 0 | 48,598 | |
| Mar 13 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 51.84 | 3,224 | 167,132 | 1,554,993 | 1.6 M to 1.6 M (-0.21 %) |
| Mar 13 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 13,237 | 0 | 1,558,217 | 1.5 M to 1.6 M (+0.86 %) |
| Mar 13 2018 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Administration ... | Payment of Exercise | F | 51.84 | 1,727 | 89,528 | 89,879 | 91.6 K to 89.9 K (-1.89 %) |
| Mar 13 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 52.82 | 5,842 | 308,574 | 29,914 | 35.8 K to 29.9 K (-16.34 %) |
| Mar 13 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 51.84 | 974 | 50,492 | 35,756 | 36.7 K to 35.8 K (-2.65 %) |
| Mar 13 2018 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 51.84 | 7,825 | 405,648 | 213,128 | 221 K to 213.1 K (-3.54 %) |
| Mar 09 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | M | 22.03 | 6,573 | 144,803 | 0 | |
| Mar 09 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 50.43 | 2,843 | 143,372 | 36,730 | 39.6 K to 36.7 K (-7.18 %) |
| Mar 09 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Buy | M | 22.03 | 6,573 | 144,803 | 39,573 | 33 K to 39.6 K (+19.92 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,723 | 0 | 61,835 | |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,794 | 0 | 71,558 | |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 49.64 | 38,577 | 1,914,962 | 38,577 | |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 19,288 | 0 | 81,352 | |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 49.97 | 2,368 | 118,329 | 1,544,980 | 1.5 M to 1.5 M (-0.15 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,723 | 0 | 1,547,348 | 1.5 M to 1.5 M (+0.63 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 49.64 | 2,385 | 118,391 | 1,537,625 | 1.5 M to 1.5 M (-0.15 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,794 | 0 | 1,540,010 | 1.5 M to 1.5 M (+0.64 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | A | 49.64 | 20,145 | 999,998 | 20,145 | |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Sell | S | 49.50 | 1,898 | 93,951 | 33,000 | 34.9 K to 33 K (-5.44 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 49.97 | 811 | 40,526 | 34,898 | 35.7 K to 34.9 K (-2.27 %) |
| Mar 01 2018 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 49.64 | 409 | 20,303 | 35,709 | 36.1 K to 35.7 K (-1.13 %) |